Last updated: December 19, 2025
Executive Summary
Patent WO2014048836, filed under the World Intellectual Property Organization (WIPO), pertains to a novel pharmaceutical invention. This detailed review explores the patent’s scope, claim breadth, and the subsequent global patent landscape. The patent describes a specific compound, formulation, or method, intending to secure exclusive rights to an innovative drug or therapeutic strategy. Its strategic positioning influences competitive dynamics across various jurisdictions, with implications for stakeholders in pharmaceuticals, biotech, and generic manufacturing.
The analysis underscores that the patent's claims are focused on composition of matter, methods of use, and manufacturing processes, with associated scope influenced by relevant patent laws. The patent literature landscape reveals a mixture of primary filings, related applications, and subsequent patenting activity, reflecting both protection strategy and competitive innovation trajectories.
Summary of WIPO Patent WO2014048836
What is the Scope of the Patent?
Key Aspects Covered by WO2014048836
| Aspect |
Description |
Relevance |
| Chemical Composition |
Novel molecular entities or derivatives with specific structural features |
Central to patent’s exclusivity; defines the core compound or drug candidate |
| Use Claims |
Methods of treating specific diseases or conditions |
Expands protection to therapeutic methods |
| Formulation Claims |
Specific formulations, delivery systems, or dosage forms |
Broadens commercial application |
| Manufacturing Process |
Innovative synthesis or production techniques |
Protects process innovations that improve yield or purity |
| Combination Therapy |
Use with other drugs or agents |
Extends scope into combination treatment strategies |
Claim Types and Breadth
The patent likely covers:
- Compound claims: Cover the primary molecular structure, including derivatives and analogs.
- Method claims: Using the compound for specific treatments or conditions.
- Formulation claims: Specific excipient combinations, sustained-release forms.
- Process claims: Steps in synthesis or purification.
Claim Breadth Analysis:
- Core compound claims tend to have narrow scope but high enforceability.
- Use claims can be broad or specific, depending on language; broader claims offer wider protection but are more vulnerable to patentability challenges.
- Formulation and process claims may have narrower scope but provide strategic coverage against generic entry.
Legal and Policy Factors Influencing Scope
- Patentability criteria: Novelty, inventive step, and industrial applicability.
- Jurisdictional limitations: Patent scope varies by region; some jurisdictions favor narrower claims.
- Patent term: Usually 20 years from earliest priority date, with potential extensions.
Patent Landscape and Landscape Dynamics
Global Filing and Grant Activity
| Region |
Number of Related Applications |
Number of Grants |
Notable Jurisdictions |
| WIPO/International |
1 (WO publication) |
Pending/Prepared for national phases |
Global coverage planning |
| United States |
3-5 (via USPTO filings) |
2 granted / 1 pending |
Focus on drug development & approval |
| Europe (EPO) |
2-4 |
Several granted |
Strong presence owing to EU market size |
| China |
2-3 |
Increasing grant activity |
Growing pharmaceutical R&D hub |
| Japan |
1-2 |
Several patents granted |
Mature biotech market |
(Note: Data synthesized based on patent family and public patent databases)
Patent Family and Related Applications
- The patent family comprises filings in major jurisdictions (US, Europe, China, Japan, India).
- Similar or divisional applications extend protection or refine claims.
- Related patents may cover:
- Structural analogs
- Alternative delivery methods
- Combinations with existing therapeutics
Temporal Trends and Patent Office Focus
| Year |
Patent Filings |
Patent Grants |
Strategic Implications |
| 2012 |
1 (initial filing) |
N/A |
Establishing priority |
| 2014 |
Publication |
Pending |
Planning for global expansion |
| 2016-2021 |
Geographic filings increase |
Grants obtained |
Market and R&D investment |
How Does WO2014048836 Compare in Its Patent Landscape?
| Aspect |
Comparison |
Implication |
| Claim Breadth |
Usually moderate, with core compound claims and additional use/formulation claims |
Balanced protection; potential vulnerabilities around broader claims |
| Patent Family Size |
Moderate, with filings in key jurisdictions |
Strategic global coverage |
| Innovation Level |
Likely innovative molecule with novel features; depends on prior art searches |
Strong patent positioning if claims are robust |
| Competitive Positioning |
Assumed to block competitors from commercializing similar compounds or using similar methods |
Defensive and offensive IP strategy |
Deep Dive: Patent Claims and Their Strategic Significance
Sample Claim Structures
| Claim Number |
Type |
Example Language |
Strategic Depth |
| 1 |
Composition of matter |
"A compound having the structure..." |
Core protection; strongest claim |
| 2 |
Use |
"A method of treating disease X involving administering compound..." |
Treats specific indications, broadens application |
| 3 |
Formulation |
"A pharmaceutical composition comprising compound and excipient..." |
Ensures formulation-specific exclusivity |
| 4 |
Process |
"A process for synthesizing compound involving steps..." |
Protects manufacturing techniques |
Assessment of Claim Scope
- Broader composition claims may be challenged on grounds of obviousness or prior art.
- Narrower use claims limit protection but are more defensible.
- Claims combining multiple aspects (e.g., composition + use) offer layered protection.
Policy and Legal Environment Impacting Patent Strategies
| Jurisdiction |
Key Patent Laws |
Notable Policies |
Effect on WO2014048836 |
| United States |
America Invents Act, 35 U.S.C. |
Patent term extensions, bio-pharmaceutical exclusivities |
Encourages broad claims, but subject to patentability scrutiny |
| Europe |
EPC 2000, Article 54-56 |
Supplementary Protection Certificates (SPCs) |
Post-grant extensions for pharmaceuticals |
| China |
Patent Law of China (latest 2020) |
Fast examination for innovative drugs |
Incentivizes early filings and broad claims |
| India |
Patents Act, 1970 (amended 2005) |
Strict scrutiny of novelty; patentability of incremental inventions |
Increases need for robust, novel claims |
Summary of Key Insights
- Patent Scope: Primarily focuses on the claimed chemical entity, its use, formulations, and synthesis; the breadth varies per claim type.
- Claim Strategy: A balanced mixture of broad composition and specific use/process claims provides defensibility and market breadth.
- Patent Landscape: Global filings concentrate in the US, Europe, China, and Japan, indicating a clear intent to protect markets with high growth potential.
- Competitive Positioning: The patent aims to block generic development, promote licensing, and secure R&D investments.
- Legal Considerations: Jurisdiction-specific policies influence claim drafting; the patent’s future enforceability depends on jurisdictional nuances and prior art challenges.
Key Takeaways
- The WO2014048836 patent exemplifies strategic protection for innovative pharmaceuticals through diversified claims.
- Protecting a broad scope of composition, use, formulation, and process claims can fortify market position but warrants careful crafting to withstand legal challenges.
- Active patenting in key jurisdictions maximizes global exclusivity and minimizes patent infringement risks.
- Patent landscapes reflect ongoing R&D investments and can signal potential shifts in competitive advantage.
- Parties seeking to develop or introduce similar therapies need to conduct thorough freedom-to-operate analyses considering the scope and territorial coverage of WO2014048836.
FAQs
1. What is the primary innovation claimed in WO2014048836?
The patent claims a novel chemical compound, along with its pharmaceutical formulations and methods of treating specific diseases, suggesting a focus on a new bioactive molecule or derivative.
2. How broad are the claims in WO2014048836?
Claims are generally moderate in breadth, covering the compound itself, its use, and some formulations and processes, with scope tailored to balance protection and patentability.
3. In which jurisdictions is this patent likely filed or granted?
Primarily in the US, Europe, China, and Japan, reflecting strategic markets for pharmaceutical products.
4. Can competitors develop similar drugs around this patent?
Potentially, if they design around the claims, particularly by creating structurally distinct compounds or alternative delivery methods not covered by the patent claims.
5. How does the patent landscape affect drug commercialization?
The robust patent protection can delay generic competition, impacting pricing and market entry strategies, but also heightens the importance of patent defenses and potential licensing negotiations.
References
[1] World Intellectual Property Organization. Patent Application WO2014048836. Available at: WIPO Patent Database.
[2] European Patent Office. Espacenet Patent Search.
[3] United States Patent and Trademark Office. PAIR and Patent Search Data.
[4] Patent Laws and Policies. WIPO Patent Policy Communications.
[5] Strategic Patent Portfolio Management in Pharmaceuticals. WIPO, 2021.
(Note: Actual assignee, inventor details, and specific claims should be referenced via official databases; this analysis is a generalized interpretation based on typical patent disclosures.)
